2m 2m 2m 2m 2m 2m 2m
IBIO (IBIO)
NASDAQ
$0.78-$0.06 (-7.02%)
Price as of Oct 22, 2026 7:59 PM EDT- $54.0MMarket Cap
- -39.57%1-Year Change
- BiotechnologyIndustry
IBIO (IBIO)
$0.78-$0.06 (-7.02%)
IBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.84 | ||
Change | +$0.02 (+2.31%) | ||
Open | $0.84 | ||
High | $0.88 | ||
Low | $0.84 | ||
Previous Close | $0.82 | ||
Volume | 517,542 | ||
30-Day Average Volume | 863,563 | ||
1-Week Change | 7.58% | ||
1-Month Change | -33.33% | ||
1-Year Change | -39.57% | ||
3-Year Change | -86.23% | ||
5-Year Change | -99.80% | ||
Fundamentals | |||
Shares Outstanding | 64.3M | ||
Total Assets | $99.1M | ||
Market Cap | $54.0M | ||
Enterprise Value | -$1.5M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$10.6M | ||
Free Cash Flow | -$6.2M | ||
EBIT | -$10.6M | ||
EBITDA | -$10.6M | ||
Net Working Capital | $80.5M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -12 | ||
PEG | 1 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 11/29/2023 | ||
Earnings & Revenue